Skripsi
HUBUNGAN KEPATUHAN MINUM OBAT DENGAN KONTROL GLIKEMIK (HBA1C) DAN FUNGSI KOGNITIF PADA PRA-LANSIA PENDERITA DIABETES MELITUS DI KOTA PALEMBANG
Background: Diabetes Mellitus (DM) is a chronic disease that may lead to long-term complications, including cognitive impairment, particularly among the pre-elderly population. Glycemic control, measured by HbA1c, is a key component of DM management and is influenced, among other factors, by medication adherence. Good glycemic control may contribute to reducing the risk of cognitive impairment. Objective: This study aimed to analyze the association between medication adherence and glycemic control (HbA1c) and cognitive function among pre-elderly patients with Diabetes Mellitus in Palembang City. Methods: This study employed a cross-sectional design conducted from August to September 2025 in six primary health centers in Palembang City. A total of 198 pre-elderly DM patients aged 45–59 years were selected using purposive sampling. Data were collected using standardized questionnaires and patients’ medical records. Data analysis included univariate analysis, bivariate analysis using the chi-square test, and multivariate analysis using multiple logistic regression. Results: Medication adherence was significantly associated with glycemic control; however, it could not be used as a predictor after adjustment for age, sex, consumption of fatty foods, smoking status, duration of diabetes, and type of therapy. Medication adherence was also not significantly associated with cognitive function after controlling for age, education level, physical activity, soft drink consumption, and vegetable intake. Conclusion: Medication adherence was identified as a risk factor for glycemic control but could not serve as a predictor after adjustment for confounding variables. Furthermore, medication adherence was not a risk factor for cognitive function after controlling for confounders
No other version available